SCHEMBL5060414

SCHEMBL5060414

CCc1nc(NC(=O)c2ccccc2O)sc1C(C)C

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 10/20 0.56
RAB9A P51151 10/20 0.56
MEN1 O00255 8/20 0.56
KMT2A Q03164 8/20 0.56
RXFP1 Q9HBX9 1/20 0.56
HTT P42858 7/20 0.50
KDM4E B2RXH2 7/20 0.50
HSD17B10 Q99714 7/20 0.50
TP53 P04637 6/20 0.50
ALDH1A1 P00352 6/20 0.50
HPGD P15428 5/20 0.50
GAA P10253 2/20 0.50
RCE1 Q9Y256 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
STAT3 P40763 1/20 0.44
USP2 O75604 1/20 0.43
LMNA P02545 8/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
TSHR P16473 2/20 0.41
MAPK1 P28482 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL330283 0.84 GPER1 (0.44) MEN1KMT2AHTTKDM4EALDH1A1
SCHEMBL31665325 0.72 RAB9A (0.59) NPC1RAB9AMEN1KMT2ARXFP1
SCHEMBL25143183 0.70 RAB9A (0.52) NPC1RAB9AMEN1KMT2ARXFP1
SCHEMBL23607124 0.70 CNR1 (0.71) NPC1RAB9AMEN1KMT2ARXFP1
SCHEMBL4268511 0.68 NPC1 (0.44) NPC1RAB9AMEN1KMT2ARXFP1
SCHEMBL330837 0.68 XIAP (0.43) NPC1RAB9AMEN1KMT2ARXFP1
SCHEMBL31665546 0.68 RAB9A (0.50) NPC1RAB9AMEN1KMT2ARXFP1
SCHEMBL25143469 0.68 RAB9A (0.50) NPC1RAB9AMEN1KMT2ARXFP1
SCHEMBL4756512 0.68 RAB9A (0.70) NPC1RAB9AMEN1KMT2ARXFP1
SCHEMBL4756657 0.68 RAB9A (0.59) NPC1RAB9AMEN1KMT2ARXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080318956-A1 INFLAMMATORY CYTOKINE RELEASE INHIBITOR INSTITUTE OF MEDICINAL MOLECULAR DESIGN. INC. (JP) 2008-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080318956-A1 INFLAMMATORY CYTOKINE RELEASE INHIBITOR IL1B, NFKBIA, IL1A NPC1 978/4885RAB9A 1124/4885MEN1 4504/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.